Solid-phase synthesis of CD40L mimetics

被引:10
作者
Bianco, A [1 ]
Fournel, S [1 ]
Wieckowski, S [1 ]
Hoebeke, J [1 ]
Guichard, G [1 ]
机构
[1] CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France
关键词
D O I
10.1039/b601528j
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The C-3-symmetric molecule 1 has been previously shown to mimic CD40 ligand (CD40L) homotrimers and to display effector functions. This molecule consists of a cyclic hexapeptide core containing the repetition of the D-Ala-L-Lys motif. The side chains of the lysine residues have been modified by appending the CD40L-derived sequence (143)Lys-Gly-Tyr-Tyr(146) via a 6-aminohexanoic acid residue as a spacer. The present report describes a general solid-phase synthesis approach to 1 and related trimeric architectures. In addition, their CD40 binding properties as well as their effector functions have been evaluated.
引用
收藏
页码:1461 / 1463
页数:3
相关论文
共 19 条
[1]   The molecular architecture of the TNF superfamily [J].
Bodmer, JL ;
Schneider, P ;
Tschopp, J .
TRENDS IN BIOCHEMICAL SCIENCES, 2002, 27 (01) :19-26
[2]   Systemic antibacterial activity of novel synthetic cyclic peptides [J].
Dartois, V ;
Sanchez-Quesada, J ;
Cabezas, E ;
Chi, E ;
Dubbelde, C ;
Dunn, C ;
Granja, J ;
Gritzen, C ;
Weinberger, D ;
Ghadiri, MR ;
Parr, TR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3302-3310
[3]   Solid-phase synthesis of diketopiperazines, useful scaffolds for combinatorial chemistry [J].
del Fresno, M ;
Alsina, J ;
Royo, M ;
Barany, G ;
Albericio, F .
TETRAHEDRON LETTERS, 1998, 39 (17) :2639-2642
[4]   CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy [J].
Diehl, L ;
den Boer, AT ;
Schoenberger, SP ;
van der Voort, EIH ;
Schumacher, TNM ;
Melief, CJM ;
Offringa, R ;
Toes, REM .
NATURE MEDICINE, 1999, 5 (07) :774-779
[5]   In situ generation of Fmoc-amino acid chlorides using bis(trichloromethyl) carbonate and its utilization for difficult couplings in solid-phase peptide synthesis [J].
Falb, E ;
Yechezkel, T ;
Salitra, Y ;
Gilon, C .
JOURNAL OF PEPTIDE RESEARCH, 1999, 53 (05) :507-517
[6]   C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L [J].
Fournel, S ;
Wieckowski, S ;
Sun, WM ;
Trouche, N ;
Dumortier, H ;
Bianco, A ;
Chaloin, O ;
Habib, M ;
Peter, JC ;
Schneider, P ;
Vray, B ;
Toes, RE ;
Offringa, R ;
Melief, CJM ;
Hoebeke, J ;
Guichard, G .
NATURE CHEMICAL BIOLOGY, 2005, 1 (07) :377-382
[7]  
GOODMAN M, 2002, HOUBEN WEYL METHOD E, V22
[8]   Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis [J].
Howard, LM ;
Miga, AJ ;
Vanderlugt, CL ;
Dal Canto, MC ;
Laman, JD ;
Noelle, RJ ;
Miller, SD .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :281-290
[9]   Backbone Amide Linker (BAL) strategy for solid-phase synthesis of C-terminal-modified and cyclic peptides [J].
Jensen, KJ ;
Alsina, J ;
Songster, MF ;
Vágner, J ;
Albericio, F ;
Barany, G .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (22) :5441-5452
[10]   An improved procedure for N- to C-directed (inverse) solid-phase peptide synthesis [J].
Johansson, A ;
Åkerblom, E ;
Ersmark, K ;
Lindeberg, G ;
Hallberg, A .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2000, 2 (05) :496-507